1Department of Anatomy, University of California, San Francisco, San Francisco, California. 2Department of Cell, Developmental & Cancer Biology, Oregon Health and ...
1The Second Clinical Medical School, Lanzhou University, Lanzhou, China. 2Department of General Surgery, Lanzhou University Second Hospital, Lanzhou, China. 3Gansu Tumor Immunology Basic Disciplines ...
Researchers used a unique base-editing strategy to engineer chimeric-antigen receptor (CAR) T cells that engraft in the host and remain invisible to remaining antibody drugs. Of the 11 patients with T ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results